SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
25-Aug-23 6:01 PM View: | Discovery Laboratories Inc. (WINT) | 23-Aug-23 | Grant | 2,033 | -- | -- | 2033% 100 to 2.13K | |
09-Jun-22 8:19 PM View: | Discovery Laboratories Inc. (WINT) | 07-Jun-22 | Grant | 5,000 | -- | -- | 100% 0 to 5.0K | |
02-Apr-07 4:38 PM View: | Atherogenics Inc. (AGIX) | 02-Apr-07 | Market Purchase | 36,000 | $2.77 | $99,576.00 | 253% 14.2K to 50.2K | (70%) |
15-Jun-06 10:00 PM View: | Atherogenics Inc. (AGIX) | 13-Jun-06 | Option Exercise | 14,204 | $7.04 | $99,996.20 | 100% 0 to 14.2K | |
29-Dec-05 1:20 PM View: | Atherogenics Inc. (AGIX) | 28-Dec-05 | Option Exercise | 16,100 | $7.04 | $113,344.00 | 413% 3.9K to 20.0K | |
29-Dec-05 1:20 PM View: | Atherogenics Inc. (AGIX) | 28-Dec-05 | Market Option Sale | 16,100 | $20.01 | $322,106.00 | (81%) 20.0K to 3.9K | 96% |
29-Dec-05 1:20 PM View: | Atherogenics Inc. (AGIX) | 28-Dec-05 | Market Sale | 3,900 | $20.01 | $78,025.70 | (100%) 3.9K to 0 | 96% |
28-Feb-05 5:46 PM View: | Atherogenics Inc. (AGIX) | 24-Feb-05 | Market Sale | 30,000 | $17.51 | $525,300.00 | (88%) 33.9K to 3.9K | 95% |
23-Jan-04 10:00 PM View: | Atherogenics Inc. (AGIX) | 21-Jan-04 | Option Exercise | 12,300 | $7.27 | $89,367.00 | 57% 21.6K to 33.9K | |
22-Oct-03 10:00 PM View: | Atherogenics Inc. (AGIX) | 21-Oct-03 | Option Exercise | 21,600 | $7.04 | $152,064.00 | 100% 0 to 21.6K |